Add office photos
Employer?
Claim Account for FREE
Ultratech India
4.0
based on 118 Reviews
Company Overview
Company Locations
Working at Ultratech India
Company Summary
Ultratech India Limited is a pharmaceutical manufacturer, producing a variety of formulations and APIs, adhering to global quality standards for varied healthcare applications.
Overall Rating
4.0/5
based on 118 reviews
3% above
industry average
Highly rated for
Job security, Company culture, Skill development
Critically rated for
Promotions
Work Policy
Work from office
85% employees reported
Monday to Saturday
67% employees reported
Flexible timing
51% employees reported
No travel
50% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
3 employees reported
Health insurance
3 employees reported
Job/Soft skill training
2 employees reported
View detailed benefits
About Ultratech India
Founded in1992 (33 yrs old)
India Employee Count11-50
Global Employee Count501-1k
India HeadquartersNavi Mumbai, India
Office Locations
--
Websiteultratechindia.com
Primary Industry
Other Industries
--
Are you managing Ultratech India's employer brand? To edit company information,
claim this page for free
Ultratech India Limited is a WHO-GMP and ISO certified Pharmaceutical company that manufactures and markets a wide range of Pharmaceutical Formulations in various dosage forms (Tablets, Capsules, Syrups, Gels, Injections, Nasal Sprays, Metered Dose Inhalers), advanced Drug Intermediates and Active Pharmaceutical Ingredients.
Ultratech was formed in 1992 & in its two decade journey established itself as a Multi-national company manufacturing world-class Pharmaceutical products with a diverse product portfolio that includes Pharmaceutical Ethical Drugs, OTC, Cosmetic and FMCG Products for a broad spectrum of applications. The company has its offices in India, Ukraine and Nigeria and a global clientele in more than 25 Countries.
Our products are manufactured in line with FDA guidelines and cGMP requirements. Most of our products are supported with DMFs, Dossiers, FSCs, COPPs and registration files for obtaining Product registrations as per Country specific requirements with the help of our highly experienced and qualified regulatory team.
Ultratech is an excellent combination of world class manufacturing, R&D, Quality control, Quality Assurance, Marketing and indepth Management expertise.
Ultratech has a team of highly qualified professionals experienced in the pharmaceutical industry. Many years of experience, achievements, a strong R&D base and quality commitment has made Ultratech a force to reckon with. Customer satisfaction is the core of our reverberating functional energy.
Managing your company's employer brand?
Claim this Company Page for FREE
Ultratech India Ratings
based on 118 reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
49
4
35
3
16
2
6
1
12
Category Ratings
4.1
Job security
3.8
Company culture
3.8
Skill development
3.7
Salary
3.7
Work-life balance
3.7
Work satisfaction
3.3
Promotions
Ultratech India is rated 4.0 out of 5 stars on AmbitionBox, based on 118 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Ultratech India
based on 112 reviews
4.1
Rated by 12 Women
Rated 4.2 for Job security and 3.8 for Company culture
3.9
Rated by 100 Men
Rated 4.1 for Job security and 3.9 for Skill development
Work Policy at Ultratech India
based on 20 reviews in last 6 months
Work from office
85%
Hybrid
10%
Permanent work from home
5%
Ultratech India Reviews
Top mentions in Ultratech India Reviews
+ 3 more
Compare Ultratech India with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 118 reviews | 3.9/5 based on 2.5k reviews | 3.9/5 based on 1.7k reviews | 3.8/5 based on 2.2k reviews |
Highly Rated for | Job security Skill development Company culture | No highly rated category | No highly rated category | No highly rated category |
Critically Rated for | Promotions | Promotions | Promotions | Promotions Job security |
Primary Work Policy | Work from office 85% employees reported | Work from office 72% employees reported | Work from office 73% employees reported | Work from office 77% employees reported |
Rating by Women Employees | 4.1 Good rated by 12 women | 3.8 Good rated by 132 women | 4.1 Good rated by 64 women | 3.6 Good rated by 23 women |
Rating by Men Employees | 3.9 Good rated by 100 men | 3.9 Good rated by 2.2k men | 3.9 Good rated by 1.6k men | 3.8 Good rated by 2.1k men |
Job security | 4.1 Good | 3.6 Good | 3.5 Good | 3.3 Average |
View more
Ultratech India Salaries
Ultratech India salaries have received with an average score of 3.7 out of 5 by 118 employees.
Officer
(9 salaries)
Unlock
₹5 L/yr - ₹9.5 L/yr
Senior Officer
(6 salaries)
Unlock
₹7 L/yr - ₹11.5 L/yr
Senior Engineer
(6 salaries)
Unlock
₹7 L/yr - ₹12.1 L/yr
Management Trainee
(6 salaries)
Unlock
₹13 L/yr - ₹14.6 L/yr
Chemist Quality Control
(6 salaries)
Unlock
₹2 L/yr - ₹2.3 L/yr
Accountant
(5 salaries)
Unlock
₹1.2 L/yr - ₹3.1 L/yr
Deputy Manager
(5 salaries)
Unlock
₹14.3 L/yr - ₹17.1 L/yr
Applications Engineer
(5 salaries)
Unlock
₹2.4 L/yr - ₹4.1 L/yr
Executive Accountant
(5 salaries)
Unlock
₹2.2 L/yr - ₹3.2 L/yr
Logistics Executive
(5 salaries)
Unlock
₹2.8 L/yr - ₹3.5 L/yr
Ultratech India Interview Questions
Interview questions by designation
Top Ultratech India interview questions and answers
Ultratech India News
View all
Ambuja Cements, UltraTech Remains Systematix' Top Stock Picks In The Sector — Here's Why
- Ambuja Cements and UltraTech are Systematix' top stock picks in the sector.
- Systematix Institutional Equities has a target price of Rs 12,660 for UltraTech and Rs 654 for Ambuja Cements.
- Cement demand has been challenged by labor shortages, transportation bottlenecks, and muted government spending.
- Cement prices are expected to rise steadily over the medium term due to improved performance, efficiency, and margins.
Bloomberg Quint | 4 Mar, 2025
Havells To Finolex: Wire And Cable Stocks Recover After Selling Pressure From UltraTech's Entry Plan
- The wire and cable sector experienced a recovery following selling pressure from UltraTech's entry plan.
- On Friday, the market capitalisation of the top cable and wire stocks grew by Rs 1,514 crore, partially recovering from a sharp decline of Rs 35,500 crore on Thursday.
- Finolex Cables saw a slight increase of 0.43% in its stock price, bringing its market cap to Rs 12,629.73 crore.
- Havells India saw a gain of 0.26%, with its market cap standing at Rs 90,737.28 crore.
Bloomberg Quint | 28 Feb, 2025
Share Market Highlights 27 February 2025: Sensex, Nifty end flat; Shriram Finance jumps over 5%
- Forex traders reacted to US tariff news, boosting the dollar with the rupee closing at 87.21 against USD amid market volatility.
- Nvidia reported impressive net income of $22.1 billion, exceeding expectations, reflecting a potential shift of investors back to the US from China.
- Nvidia's recent financial performance had a rangebound market reaction due to factors like a slight dip in gross profit margins, competition, and customer concentration.
- Despite facing challenges like a dip in gross margins, Nvidia's CEO emphasized the superiority of their chips in the AI ecosystem, leading to a bullish sentiment among analysts.
- Nvidia's focus on its new-gen Blackwell chips and upcoming GTC conference point towards future growth potential.
- In the stock market, Tata Motors, UltraTech, and other companies witnessed fluctuations, while overall equity benchmarks faced volatility during F&O expiry.
- Market sentiments were affected by developments like copper futures expected rise, UltraTech's entry into the Cable & Wire segment, and concerns over global economic uncertainty.
- Indian economy remains stable despite global uncertainties, with GDP growth projected between 6-7% for 2024-25, and listed funds experiencing outflows in January.
- RBI's decision to reduce risk weights on bank loans to NBFCs and MFIs is viewed positively by analysts, potentially aiding credit flow and easing funding costs.
- Various companies across sectors like technology, healthcare, and media, including eBay and Warner Bros. Discovery, reported earnings with mixed results against estimates.
- Key financial indicators and economic factors, such as US tariff impacts and India's trade negotiations, continue to drive market movements, influencing investor sentiment.
HinduBusinessLine | 27 Feb, 2025
Polycab, KEI Industries, RR Kabel, Havells and Finolex Cables crash on UltraTech’s entry into cables & wires space
- UltraTech's entry into the cables and wires space resulted in a crash in the stock prices of Polycab, KEI Industries, RR Kabel, Havells, and Finolex Cables.
- Analysts anticipate a de-rating in valuation multiples for other players in the space. However, KEI, Polycab, and Havells are expected to remain bullish.
- Nuvama Institutional Equities states that UltraTech's entry is unlikely to impact the FY25-28 earnings of cables and wires players.
- ICICI Securities predicts a potential contraction in margins for players due to aggressive pricing by UltraTech.
HinduBusinessLine | 27 Feb, 2025
UltraTech ventures into wires, cable manufacturing with ₹1,800 cr investment
- UltraTech, a leading construction materials company, is set to venture into wires and cable manufacturing with a ₹1,800 crore investment.
- The company's first manufacturing plant in this segment will be established near Bharuch in Gujarat and is expected to be operational by December 2026.
- This expansion aligns with UltraTech's strategy to become a comprehensive building solutions provider and tap into the growing demand for wires and cables in various sectors.
- UltraTech's entry into the wires and cables industry aims to leverage its manufacturing expertise to deliver high-quality products and capture a larger market share.
HinduBusinessLine | 25 Feb, 2025
Stock Recommendations Today: Shriram Finance, Maruti Suzuki, HUL, Nazara Tech On Brokerages' Radar
- Analyst calls for Shriram Finance, Maruti Suzuki, HUL, Nazara Technologies, and Tata Consumer Products are highlighted today.
- Morgan Stanley advocates an 'overweight' rating on Indian equities, expecting a potential outperformance to emerging markets.
- Citi Research notes the considerable correction in equities and views valuations of large-cap stocks as reasonable.
- Citi remains positive on Indian markets, recommending stocks like Maruti Suzuki, HDFC Bank, and Kotak Mahindra Bank.
- Cement sector analysis by Morgan Stanley includes ratings for UltraTech, Shree Cement, and Dalmia Bharat, predicting positive momentum.
- Citi's insights on companies like Shriram Finance, HUL, Maruti Suzuki, and Tata Consumer Products provide target prices and strategic analysis.
- CLSA's cautious outlook on Nazara Technologies and UBS's optimism on PCBL and Persistent Systems are also covered in analyst recommendations.
- JPMorgan offers insights on Persistent Systems, KFin Technologies, and Max Healthcare, highlighting growth potential and ratings for these companies.
Bloomberg Quint | 18 Feb, 2025
Stocks To Watch: Mahindra Lifespace, Bank Of Baroda, TCS, Piramal Enterprises, UltraTech
- Mahindra Lifespace Developers Ltd. board approved raising up to Rs 1,500 crore through rights issue.
- Manappuram Finance Ltd. approved raising up to $2 billion under the global medium-term note program.
- Bank of Baroda approved raising up to Rs 8,500 crore through qualified institutional placements.
- Tata Consultancy Services entered into an agreement with UPM to lead its comprehensive transformation.
Bloomberg Quint | 14 Feb, 2025
Stocks that will see action today: February 6, 2025
- Life Insurance Corporation of India (LIC) has received a demand notice of about Rs 105.42 crore for short payment of Goods and Services Tax (GST) for seven financial years.
- Patanjali Group has partnered with IBSFINtech for integrated treasury management solutions for digital transformation.
- Apollo Micro Systems Limited has entered into a consortium agreement with Redon Systems Pvt Ltd. to collaborate on a manufacturing partnership.
- GE Power India has received a purchase order from NTPC, for an amount of ₹13.75 crore (excluding 18% GST).
- Welspun Corp approved sale of 1,900 equity shares holdings and investment of up to ₹250 crore in its subsidiary company.
- UltraTech has commissioned an additional 0.6 mtpa grinding capacity at its existing unit situated at Sonar Bangla, West Bengal.
- Container Corporation of India has raised demand of GST for FY 2017-18 to 2022-23 of ₹13.17 crore plus penalty of ₹13.17crore.
- Religare Enterprises's independent director Hamid Ahmed resigned from the board of the company.
- ITC Limited announced the opening of its global centre of excellence for Artificial Intelligence (AI) in Kolkata.
- JSW Group has expressed interest in entering the airport infrastructure and management sector.
- IndiGo has received a notice with penalties totalling ₹115.87 crore from GST authorities.
- Info Edge has approved to enter into a contribution agreement with the IE Venture Investment Fund III.
HinduBusinessLine | 6 Feb, 2025
UltraTech plans targeted action to achieve turnaround for India Cements in 12 months
- UltraTech is planning targeted actions to achieve a turnaround for India Cements within 12 months.
- India Cements reported a loss of ₹429 crore in the December 2024 quarter, compared to ₹17 crore in the same period last year.
- UltraTech is working to identify growth opportunities at India Cements, including debottlenecking and expansion prospects.
- UltraTech aims to enhance India Cements' performance through investment in waste heat recovery systems and expects to see improvements by the end of FY25.
HinduBusinessLine | 27 Jan, 2025
UltraTech to report fall in Q3 net profit
- UltraTech is expected to report a fall in Q3 net profit according to estimates by leading brokerage houses.
- Revenue from operations is projected to increase marginally by just one per cent year-on-year.
- EBITDA for the quarter is estimated to decline 14 per cent year-on-year and operating margins may contract by 3.1 percentage points to 16 per cent.
- Analysts anticipate varying volumes and EBITDA per tonne, with expectations of price hikes, lower costs, and improved cost efficiency.
HinduBusinessLine | 23 Jan, 2025
Powered by
Ultratech India Offices
Compare Ultratech India with
Grasim Industries
4.0
JK Cement
4.1
The Ramco Cements
4.2
Dalmia Bharat Cement
4.0
India Cements
3.8
Birla Corporation
4.1
Heidelberg Cement
4.2
Symbiotec Pharmalab
3.9
Recipharm Pharmaservices
3.9
Abbott Nutrition International
3.9
Med Manor Organics
3.3
Torque Pharmaceuticals
3.7
Walter Bushnell
3.3
VWR International
3.6
Ferring Pharmaceuticals
4.0
Tirupati Life Sciences
4.1
Multani Pharmaceuticals
3.9
Kinapse
4.2
Aurore Life Sciences
3.0
Oman Pharmaceutical Products
2.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Ultratech India
Ambuja Cements
Building Material, Engineering & Construction
3.9
• 1.7k reviews
ACC
Building Material, Engineering & Construction
3.9
• 2.5k reviews
Shree Cement
Building Material, Engineering & Construction
3.8
• 2.2k reviews
Grasim Industries
Chemicals / Agri Inputs, Building Material, Manufacturing, Non-Profit, Fashion & Textile, Engineering & Construction
4.0
• 2.6k reviews
JK Cement
Building Material, Engineering & Construction
4.1
• 2.8k reviews
The Ramco Cements
Building Material, Manufacturing, Engineering & Construction
4.2
• 940 reviews
Dalmia Bharat Cement
Building Material, Engineering & Construction
4.0
• 2.1k reviews
India Cements
Building Material, Engineering & Construction
3.8
• 616 reviews
Birla Corporation
Building Material, Iron & Steel, Manufacturing, Fashion & Textile, Engineering & Construction
4.1
• 855 reviews
Heidelberg Cement
Building Material, Manufacturing, Engineering & Construction
4.2
• 459 reviews
Symbiotec Pharmalab
Manufacturing, Pharma
3.9
• 347 reviews
Recipharm Pharmaservices
Manufacturing, Pharma
3.9
• 267 reviews
Ultratech India FAQs
When was Ultratech India founded?
Ultratech India was founded in 1992. The company has been operating for 33 years primarily in the Pharma sector.
Where is the Ultratech India headquarters located?
Ultratech India is headquartered in Navi Mumbai.
How many employees does Ultratech India have in India?
Ultratech India currently has more than 20+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in Ultratech India based on the number of reviews submitted on AmbitionBox.
Does Ultratech India have good work-life balance?
Ultratech India has a Work-Life Balance Rating of 3.7 out of 5 based on 100+ employee reviews on AmbitionBox. 71% employees rated Ultratech India 4 or above, while 29% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Ultratech India work-life balance reviews for more details
Is Ultratech India good for career growth?
Career growth at Ultratech India is rated as moderate, with a promotions and appraisal rating of 3.3. 29% employees rated Ultratech India 3 or below, while 71% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Ultratech India promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Ultratech India?
Working at Ultratech India comes with several advantages and disadvantages. It is highly rated for job security, company culture and skill development. However, it is poorly rated for promotions / appraisal, based on 100+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
